184 related articles for article (PubMed ID: 21301986)
21. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.
Capussotti L; Muratore A; Baracchi F; Lelong B; Ferrero A; Regge D; Delpero JR
Arch Surg; 2008 Oct; 143(10):978-82; discussion 982. PubMed ID: 18936377
[TBL] [Abstract][Full Text] [Related]
22. Portal Vein Embolization (PVE)
Treska V; Fichtl J; Ludvik J; Bruha J; Liska V; Treskova I; Kucera R; Topolcan O; Lysak D; Skalicky T; Ferda J
Anticancer Res; 2018 Sep; 38(9):5531-5537. PubMed ID: 30194213
[TBL] [Abstract][Full Text] [Related]
23. The management of solitary colorectal liver metastases.
Brouquet A; Andreou A; Vauthey JN
Surgeon; 2011 Oct; 9(5):265-72. PubMed ID: 21843821
[TBL] [Abstract][Full Text] [Related]
24. Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases.
Pamecha V; Nedjat-Shokouhi B; Gurusamy K; Glantzounis GK; Sharma D; Davidson BR
Dig Surg; 2008; 25(5):387-93. PubMed ID: 19033722
[TBL] [Abstract][Full Text] [Related]
25. General principles of hepatectomy in colorectal liver metastases.
Maroulis I; Karavias DD; Karavias D
Tech Coloproctol; 2011 Oct; 15 Suppl 1():S13-6. PubMed ID: 21887560
[TBL] [Abstract][Full Text] [Related]
26. [Colorectal liver metastases surgery - the present and the perspectives].
Třeška V; Skalický T; Ferda J; Fínek J; Liška V
Rozhl Chir; 2014 Dec; 93(12):568-71. PubMed ID: 25472561
[TBL] [Abstract][Full Text] [Related]
27. An update on chemotherapy of colorectal liver metastases.
Wang CC; Li J
World J Gastroenterol; 2012 Jan; 18(1):25-33. PubMed ID: 22228967
[TBL] [Abstract][Full Text] [Related]
28. Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome.
Abdalla EK
J Surg Oncol; 2010 Dec; 102(8):960-7. PubMed ID: 21165999
[TBL] [Abstract][Full Text] [Related]
29. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.
Abdalla EK; Bauer TW; Chun YS; D'Angelica M; Kooby DA; Jarnagin WR
HPB (Oxford); 2013 Feb; 15(2):119-30. PubMed ID: 23297723
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases.
Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B
Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138
[TBL] [Abstract][Full Text] [Related]
31. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
Covey AM; Brown KT; Jarnagin WR; Brody LA; Schwartz L; Tuorto S; Sofocleous CT; D'Angelica M; Getrajdman GI; DeMatteo R; Kemeny NE; Fong Y
Ann Surg; 2008 Mar; 247(3):451-5. PubMed ID: 18376189
[TBL] [Abstract][Full Text] [Related]
32. [A curative resection with the combination of portal vein branch embolization and systemic chemotherapy in a patient with synchronous multiple and bilobar colorectal liver metastases].
Iida A; Yoshidome H; Kaneko T; Shimizu K; Mishima T; Muto T; Miyazaki M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2190-2. PubMed ID: 20037366
[TBL] [Abstract][Full Text] [Related]
33. Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review).
Al Bandar MH; Kim NK
Oncol Rep; 2017 May; 37(5):2553-2564. PubMed ID: 28350137
[TBL] [Abstract][Full Text] [Related]
34. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.
Azoulay D; Castaing D; Smail A; Adam R; Cailliez V; Laurent A; Lemoine A; Bismuth H
Ann Surg; 2000 Apr; 231(4):480-6. PubMed ID: 10749607
[TBL] [Abstract][Full Text] [Related]
35. [Process in surgical exeresis of colorectal cancer liver metastases].
Jaeck D; Bachellier P; Weber JC; Oussoultzoglou E; Greget M
Bull Acad Natl Med; 2003; 187(5):863-76; discussion 876-9. PubMed ID: 14979052
[TBL] [Abstract][Full Text] [Related]
36. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases.
Yamashita S; Shindoh J; Mizuno T; Chun YS; Conrad C; Aloia TA; Vauthey JN
J Hepatol; 2017 Jul; 67(1):56-64. PubMed ID: 28192187
[TBL] [Abstract][Full Text] [Related]
37. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review.
Moris D; Ronnekleiv-Kelly S; Rahnemai-Azar AA; Felekouras E; Dillhoff M; Schmidt C; Pawlik TM
J Gastrointest Surg; 2017 Jun; 21(6):1076-1085. PubMed ID: 28364212
[TBL] [Abstract][Full Text] [Related]
38. Two-stage hepatectomy: who will not jump over the second hurdle?
Turrini O; Ewald J; Viret F; Sarran A; Goncalves A; Delpero JR
Eur J Surg Oncol; 2012 Mar; 38(3):266-73. PubMed ID: 22244437
[TBL] [Abstract][Full Text] [Related]
39. Strategies to increase the resectability of liver metastases from colorectal cancer.
Fusai G; Davidson BR
Dig Surg; 2003; 20(6):481-96. PubMed ID: 13679642
[TBL] [Abstract][Full Text] [Related]
40. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization.
Akasu T; Moriya Y; Takayama T
Jpn J Clin Oncol; 1997 Oct; 27(5):331-5. PubMed ID: 9390211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
